HaberlandME, FogelmanAM. The role of altered lipoproteins in the pathogenesis of atherosclerosis. Am Heart J1987;113:573-7.
3.
RossR.The pathogenesis of atherosclerosis–-an update. N Engl J Med1986;314:488-500.
4.
SteinbergD, ParthasarathyS, CarewT, KhooJ, WitzumJ.Beyond cholesterol. Modification of LDL that increases its atherogenicity. N Engl J Med1989;320:915-24.
5.
National Education Programs Working Group Report on the Management of Patients with Hypertension and High Blood Cholesterol.Ann Intern Med1991;114:224-37.
6.
De WhalleyCV, RankinSM, HoultJRS, JessupW, LeakeDS.Flavonoids inhibit the oxidative modification of low density lipoproteins. Biochem Pharmacol1990;39:1743-9.
7.
HertogMG, HollmanPC, KatanMB, KromhoutD.Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutr Cancer1993;20:21-9.
8.
TorelJ, CillardJ, CillardP.Antioxidant activity of flavonoids and reactivity with peroxy radical. Phytochemistry1986;25:383-5.
9.
HusainRS, CillardJ, CillardP.Hydroxyl radical scavenging activity of flavonoids. Phytochemistry1987;26:2489-91.
10.
Negre-SalvayreA, SalvayreR.Quercetin prevents the cytotoxicity of oxidized low-density lipoproteins by macrophages. Free Radic Biol Med1992;12:101-6.
11.
RankinSM, De WhalleyCV, HoultRS, JessupW, WilkinsGM, CollardJ,. The modification of low density lipoprotein by the flavonoids myricetin and gossypetin. Biochem Pharmacol1993;45(1):67-75.
12.
GuglerR, LeschikM, DenglerHI. Disposition of quercetin in man after single oral and intravenous doses. Euro J Pharmacol1975;9:229-34.
13.
HertogMG, FeskensEJ, HollmanPC, KatanMB, KromhoutD.Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet1993;342:1007-11.
